Evidence map›Paper›PMID 40269620›Full record

ArticleJournal of clinical research in pediatric endocrinology2026

Novel

Mehmet Eltan, Hilal Sekizkardeş, Sezin Canbek, Murat Hakkı Yarar, Saygın Abalı, Zehra Yavaş Abalı

Abstract readCase Reports
In one paragraph

Article in Journal of clinical research in pediatric endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mehmet EltanUniversity of Health Sciences Türkiye, Sancaktepe Şehit Prof. Dr. İlhan Varank Training and Research Hospital, Clinic of Pediatric Endocrinology, İstanbul, TürkiyeORCID 0000-0001-6977-9620
Hilal SekizkardeşUniversity of Health Sciences Türkiye, Sancaktepe Şehit Prof. Dr. İlhan Varank Training and Research Hospital, Clinic of Pediatric Endocrinology, İstanbul, TürkiyeORCID 0000-0002-6482-870X
Sezin CanbekUniversity of Health Sciences Türkiye, Ümraniye Training and Research Hospital, Clinic of Medical Genetics, İstanbul, TürkiyeORCID 0000-0001-9516-0047
Murat Hakkı YararUniversity of Health Sciences Türkiye, Ümraniye Training and Research Hospital, Clinic of Medical Genetics, İstanbul, TürkiyeORCID 0000-0001-8481-9803
Saygın AbalıAcıbadem Mehmet Ali Aydınlar University Faculty of Medicine, Department of Pediatric Endocrinology, İstanbul, TürkiyeORCID 0000-0001-6552-2801
Zehra Yavaş AbalıMarmara University Pendik Training and Research Hospital, Department of Pediatric Endocrinology and Diabetes, İstanbul, TürkiyeORCID 0000-0002-8971-6181

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis is essential for the regulation of growth. IGF1 exerts its effects through the IGF1 receptor type 1 (IGF1R) that plays a pivotal role in fetal and postnatal growth. Pathogenic monoallelic

Indexed as

DwarfismGrowth DisordersHuman Growth HormoneReceptor, IGF Type 1Body HeightChildHumansInsulin-Like Growth Factor IMaleTreatment OutcomeHuman Growth HormoneIGF1R protein, humanInsulin-Like Growth Factor IReceptor, IGF Type 1growth hormoneIGF1IGF1Rshort stature

Identifiers

PMID40269620
PMCPMC13554952

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.